Analogs of Luteinizing Hormone-Releasing Hormone in the Treatment of Endometriosis
LHRH agonists and antagonists are used to treat endometriosis by reducing estrogen levels, with agonists serving as second-line therapy or prior to IVF, and antagonists offering potential for long-term treatment without add-back.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
My notes (saved in your browser only)
Condition tags
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (58)
- A comparison of nafarelin acetate and danazol in the treatment of endometriosis via openalex
- Administration of nasal nafarelin as compared with oral danazol for endometriosis. A multicenter double-blind comparative clinical trial via openalex
- Advances in the management of endometriosis: an update for clinicians via openalex
- Buserelin acetate in the treatment of pelvic pain associated with minimal and mild endometriosis: a controlled study via openalex
- Buserelin versus danazol in the treatment of endometriosis-associated infertility via openalex
- Depot leuprolide versus danazol in treatment of women with symptomatic endometriosis. I. Efficacy results via openalex
- Dienogest is as effective as intranasal buserelin acetate for the relief of pain symptoms associated with endometriosis--a randomized, double-blind, multicenter, controlled trial via openalex
- Dienogest is as effective as triptorelin in the treatment of endometriosis after laparoscopic surgery: results of a prospective, multicenter, randomized study via openalex
- Effect of endometriosis on in vitro fertilization via openalex
- Effect of GnRH analogues on apoptosis and release of interleukin-1beta and vascular endothelial growth factor in endometrial cell cultures from patients with endometriosis via openalex
- Effect of prolonged gonadotropin-releasing hormone agonist therapy on the outcome of in vitro fertilization-embryo transfer in patients with endometriosis via openalex
- Effects of triptorelin versus placebo on the symptoms of endometriosis via openalex
- Elagolix treatment for endometriosis-associated pain: results from a phase 2, randomized, double-blind, placebo-controlled study via openalex
- Elevated expression of tumour necrosis factor alpha in cultured granulosa cells from women with endometriosis via openalex
- Endometrial quality in infertile women with endometriosis via openalex
- Endometriosis is not detrimental to embryo implantation in oocyte recipients via openalex
- Endometriosis: treatment strategies via openalex
- Expression of GnRH receptor gene in human ectopic endometrial cells and inhibition of their proliferation by leuprolide acetate via openalex
- Gonadotropin-releasing hormone agonist induces apoptosis and reduces cell proliferation in eutopic endometrial cultures from women with endometriosis via openalex
- Gonadotropin-releasing hormone agonist plus "add-back" hormone replacement therapy for treatment of endometriosis: a prospective, randomized, placebo-controlled, double-blind trial via openalex
- Gonadotropin-releasing hormone agonist treatment reduced serum interleukin-6 concentrations in patients with ovarian endometriomas via openalex
- High rates of pregnancy after long-term down-regulation of women with severe endometriosis via openalex
- Inhibin A, inhibin B and activin A in follicular fluid of infertile women with tubal damage, unexplained infertility and emdometriosis via openalex
- LH-RH analogues: I. Their impact on reproductive medicine via openalex
- Long-term use of gonadotropin-releasing hormone analogs and hormone replacement therapy in the management of endometriosis: a randomized trial with a 6-year follow-up via openalex
- Long-term use of gonadotropin-releasing hormone analogues before IVF in women with endometriosis via openalex
- Menotropin stimulation after prolonged gonadotropin releasing hormone agonist pretreatment for in vitro fertilization in patients with endometriosis via openalex
- Nafarelin for endometriosis: a large-scale, danazol-controlled trial of efficacy and safety, with 1-year follow-up via openalex
- Nafarelin in the treatment of pelvic pain caused by endometriosis via openalex
- Nafarelin versus danazol in the treatment of endometriosis via openalex
- One year comparison between two add-back therapies in patients treated with a GnRH agonist for symptomatic endometriosis: a randomized double-blind trial via openalex
- Optimizing gonadotropin-releasing hormone agonist therapy in women with endometriosis via openalex
- Outcome of patients with endometriosis in assisted reproduction: results from in-vitro fertilization and oocyte donation via openalex
- Postsurgical medical treatment of advanced endometriosis: results of a randomized clinical trial via openalex
- Pre or post-operative medical treatment with nafarelin in stage III-IV endometriosis: a French multicenter study via openalex
- Prolonged gonadotropin-releasing hormone agonist treatment of symptomatic endometriosis: the role of cyclic sodium etidronate and low-dose norethindrone “add-back” therapy via openalex
- Quantitative analysis of estrogen receptor alpha and beta messenger ribonucleic acid levels in normal endometrium and ovarian endometriotic cysts using a real-time reverse transcription-polymerase chain reaction assay via openalex
- The follicular and endocrine environment in women with endometriosis: local and systemic cytokine production via openalex
- The impact of long-term gonadotropin-releasing hormone analogue treatment on preclinical abortions in patients with severe endometriosis undergoing in vitro fertilization-embryo transfer via openalex
- The value of pre-treatment with gonadotrophin releasing hormone (GnRH) analogue in IVF-ET therapy of severe endometriosis via openalex
- Treatment of endometriosis via openalex
- Use of GnRH antagonists in the treatment of endometriosis via openalex
- Use of nafarelin versus placebo after reductive laparoscopic surgery for endometriosis via openalex
- W2073888690 via openalex
- W2147018260 via openalex
- W2022164454 via openalex
- W2028587418 via openalex
- W1976687715 via openalex
- W2172273432 via openalex
- W2292879214 via openalex
- W2075125209 via openalex
- W2412382222 via openalex
- W2123876576 via openalex
- W2070069356 via openalex
- W84660312 via openalex
- W2004594777 via openalex
- W2140246703 via openalex
- W2101417341 via openalex
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- unpaywall
- last seen: 2026-11-15T06:25:32.826932+00:00